Article Detail - JF Part A
Self-Administered Drug Exclusion List (A53033) - R48 - Effective August 29, 2026
Date Posted: July 16, 2026
This billing and coding article has been revised and published for notice under contract numbers: 02101 (AK), 02201 (ID), 02301(OR), 02401 (WA), 03101 (AZ), 03201 (MT), 03301 (ND), 03401 (SD), 03501 (UT), and 03601 (WY).
Effective Date: August 29, 2026
Summary of Changes:
Under Excluded CPT/HCPCS Codes, added Q5164 Injection, ustekinumab-hmny (starjemza), biosimilar, 1 mg* and J3490, J3590, C9399 bimekizumab-bkzx (Bimzelx®)
Visit the Self-Administered Drugs (SADs) webpage to view the Self-Administered Drug Exclusion List.
To view the complete listing of billing and coding articles and/or access the Active, Future, or Retired articles available in the CMS MCD, visit the Billing and Coding Articles webpage.